Current state of cancer immunity cycle: new strategies and challenges of using precision hydrogels to treat breast cancer
The cancer-immunity cycle provides a framework for a series of events in anti-cancer immune responses, initiated by T cell-mediated tumor cell killing, which Heartrate Electrode leads to antigen presentation and T cell stimulation.Current immunomodulatory therapies for breast cancer are often associated with short duration, poor targeting to sites